The SPRAY study (Sativex® for Pain Research in Advanced malignancY) is a medical research study looking at whether an investigational medication, Sativex®, is effective in managing persistent cancer pain in approximately 336 patients worldwide.
Investigational means it has not been approved by all the necessary regulatory agencies where this study is taking place. Sativex® has been approved in Canada as an add-on treatment for pain in patients with advanced cancer.
In this study, Sativex® comes in the form of a metered dose oro-mucosal spray (like a breath freshener), taken by spraying it inside the cheeks of your mouth. More details on how to take this study medication will be provided to you upon study entry.